PX1 Research provides certified, high-purity N-Acetyl Semax (NA Semax) strictly for laboratory research and preclinical evaluation. Every lot is manufactured in USA-based, GMP-compliant facilities and thoroughly characterized using reverse-phase HPLC and mass spectrometry. Researchers sourcing NA Semax receive lot-specific Certificates of Analysis confirming sequence integrity, minimal bioburden, and precise chemical identity.
PX1 Research provides certified, high-purity N-Acetyl Semax (NA Semax) strictly for laboratory research and preclinical evaluation. Every lot is manufactured in USA-based, GMP-compliant facilities and thoroughly characterized using reverse-phase HPLC and mass spectrometry. Researchers sourcing NA Semax receive lot-specific Certificates of Analysis confirming sequence integrity, minimal bioburden, and precise chemical identity.
When evaluating NA Semax for sale for laboratory research use, investigators require verifiable purity, batch-level transparency, and documented chemical identity. PX1 Research supplies high-purity N-Acetyl Semax synthesized in USA-based, GMP-compliant facilities. Every lot undergoes rigorous HPLC and mass spectrometry testing to guarantee precise sequence fidelity and minimal bioburden for in vitro and preclinical applications.
Sourcing synthetic peptides for controlled laboratory environments demands rigorous vendor qualification. Research institutions and qualified investigators must ensure that compounds designated as N-Acetyl Semax undergo systematic analytical validation prior to experimental deployment. Impurities introduced during solid-phase peptide synthesis (SPPS)—such as truncated fragments, deletion sequences, or residual organic solvents—can alter baseline cellular responses and invalidate in vitro assays.
PX1 Research maintains a fully controlled supply chain to eliminate variability in experimental models. By offering reference-grade NA Semax alongside comprehensive batch records, our facility enables laboratories to maintain reproducible experimental parameters across long-term investigative projects. Browse our full directory of all peptides to compare available regulatory sequence modifications.
N-Acetyl Semax is a synthetic heptapeptide analog derived from the naturally occurring adrenocorticotropic hormone fragment ACTH(4-10). The parent peptide sequence, Met-Glu-His-Phe-Pro-Gly-Pro, was originally developed to capture the neuroregulatory activity of ACTH without triggering adrenocortical steroidogenesis. The N-acetylated variant incorporates an acetyl group at the N-terminal methionine residue, resulting in the structural formula Ac-Met-Glu-His-Phe-Pro-Gly-Pro.
The addition of the N-terminal acetyl moiety alters the physicochemical profile of the peptide. In biochemical assays, N-terminal acetylation reduces susceptibility to exopeptidase cleavage by aminopeptidases, thereby extending the enzymatic half-life of the compound in biological matrices such as blood plasma and brain homogenates. This molecular modification increases metabolic resistance while maintaining the core electrostatic and conformational properties required for receptor interactions.
Understanding these structural refinements is vital for investigators examining peptidase degradation kinetics, peptide stability, and target receptor persistence in preclinical designs. Researchers exploring molecular modifications in ACTH derivatives can reference our broader research library for detailed structural analyses.
Preclinical investigations into NA Semax focus predominantly on its capacity to modulate neurotrophic factor expression in central nervous system models. Brain-Derived Neurotrophic Factor (BDNF) and its primary tropomyosin receptor kinase B (TrkB) signaling cascade play fundamental roles in neuronal plasticity, synaptic consolidation, and cellular survival. In vitro data indicate that exposure to ACTH(4-10) regulatory peptide analogs correlates with statistically significant up-regulation of BDNF mRNA expression in cortical and hippocampal neuronal cultures.
Rodent models examining neurotrophic gene expression demonstrate that administration of acetylated Semax derivatives leads to rapid transcriptional activation of BDNF alongside nerve growth factor (NGF). Researchers observe that this elevation in BDNF transcript levels coincides with increased downstream phosphorylation of extracellular signal-regulated kinase (ERK) and Akt pathways, which serve as key mediators of intracellular survival signaling.
These preclinical findings provide a mechanistic framework for studying how synthetic ACTH analogs influence structural remodeling and dendritic spine density in primary cell cultures. Investigating these neurotrophic cascades allows laboratories to map out the precise molecular sequences governing peptide-induced gene transcription.
In addition to neurotrophic up-regulation, NA Semax is widely investigated for its protective cellular responses under induced neurological stress. Preclinical models of ischemic injury, hypoxia, and oxidative damage utilize NA Semax to evaluate cellular resilience, metabolic preservation, and inflammatory signaling modulation.
In vitro models of oxygen-glucose deprivation (OGD) in primary cerebrocortical neurons show that treatment with N-acetylated ACTH(4-10) fragments limits excitotoxic calcium influx and preserves mitochondrial membrane potential. Animal studies involving middle cerebral artery occlusion (MCAO) report that localized peptide presence correlates with reduced infarct volumes and decreased expression of pro-inflammatory cytokines, including interleukin-1 beta (IL-1β) and tumor necrosis factor-alpha (TNF-α).
Furthermore, preclinical evidence indicates that NA Semax influences microvascular permeability and local nitric oxide (NO) synthase activity during acute hypoxic conditions. By regulating endothelial response factors, the peptide helps maintain microvascular integrity in experimental models of focal ischemia.
To select the appropriate analog for specific research protocols, laboratories frequently conduct comparative evaluations across related central nervous system peptides. Within the ACTH(4-10) derivative family, structural variations directly impact enzymatic stability, receptor affinity, and cellular duration.
Unmodified Semax provides the baseline heptapeptide sequence (Met-Glu-His-Phe-Pro-Gly-Pro), exhibiting rapid onset in cellular models but lower resistance to terminal aminopeptidases. The N-acetylated modification found in NA Semax enhances protection against N-terminal enzymatic degradation. For studies requiring maximal enzymatic resistance, investigators often compare this with NA Semax Amidate, which incorporates both N-terminal acetylation and C-terminal amidation to protect against carboxypeptidases. Beyond the ACTH lineage, researchers frequently benchmark these compounds against Selank, a synthetic heptapeptide derived from tuftsin that operates through distinct GABAergic and immunomodulatory pathways.
Evaluating these compounds side-by-side allows research teams to determine whether single or double terminal modifications are necessary for their specific enzymatic or cell-culture environment. For a detailed breakdown of structural differences between these regulatory sequences, consult our comparative guide on Semax vs Selank.
A critical requirement when sourcing NA Semax for sale is verifying the analytical purity of each batch. Substandard or unverified peptide preparations can introduce unintended artifacts into cellular assays, skewing quantitative RT-PCR and Western blot metrics. PX1 Research enforces strict quality assurance protocols to guarantee that every vial meets exacting scientific specifications.
Chemical identity and purity are validated using two complementary analytical techniques: High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS). Reverse-phase HPLC (RP-HPLC) isolates the primary peptide peak from synthesis byproducts, quantifying purity as a relative peak area percentage. PX1 Research mandates a minimum purity threshold of 99% for all research peptide batches.
Electrospray Ionization Mass Spectrometry (ESI-MS) or MALDI-TOF analysis is simultaneously conducted to confirm exact molecular weight. Mass spectrometry verifies that the synthesized peptide matches the theoretical mass of N-Acetyl Semax (molecular formula C39H53N9O11S, monoisotopic mass 855.36 Da) within strict mass tolerance limits. Every shipment includes a lot-specific Certificate of Analysis (COA) detailing these chromatographic and mass spectral findings.
For cell culture studies, primary neuronal assays, and sensitive analytical preparations, endotoxin contamination presents a major confounding variable. Bacterial endotoxins—specifically lipopolysaccharides (LPS) derived from Gram-negative outer membranes—trigger immune activation, cytokine release, and cell death in vitro at extremely low concentrations.
PX1 Research performs standardized Limulus Amebocyte Lysate (LAL) testing on every production lot of NA Semax. By quantifying endotoxin units per milligram (EU/mg), we ensure that bioburden remains well below critical experimental thresholds (typically <0.1 EU/mg). This stringent control prevents LPS-induced inflammatory signaling from obscuring the true biological effects of the peptide under investigation.
Additionally, environmental bioburden is minimized by carrying out post-synthesis purification, filtration, and lyophilization inside ISO-certified cleanroom environments. Laboratories procuring research compounds through our wholesale lab portal receive full documentation regarding bioburden controls and batch-level sterility standards.
Proper handling and reconstitution protocols are essential to preserve the structural stability of lyophilized NA Semax in laboratory settings. Lyophilized peptide cakes should be stored in commercial freezers at -20°C or -80°C upon receipt to prevent thermal degradation or moisture absorption.
When preparing solutions for laboratory assays, vials should be allowed to equilibrate to room temperature before opening to prevent condensation inside the container. Reconstitution should be performed using sterile, laboratory-grade solvents such as Bacteriostatic Water (0.9% benzyl alcohol) or sterile 0.9% Sodium Chloride Injection, depending on the requirements of the downstream assay system. The solvent should be gently directed along the inner glass wall of the vial rather than sprayed directly onto the peptide cake.
Resuspension is achieved through gentle swirling or slow inversion; aggressive vortexing should be avoided as mechanical shear forces can induce peptide denaturation or aggregation. Once reconstituted, liquid solutions should be aliquoted into single-use microcentrifuge tubes to minimize freeze-thaw cycles and stored at 2°C to 8°C for short-term use, or frozen at -20°C for extended storage. For additional details on peptide handling in laboratory settings, review our neuropeptides overview.
The reliability of preclinical research depends on supply chain integrity and absolute manufacturing consistency. Overseas manufacturers frequently aggregate batches from unverified synthesis facilities, leading to wide lot-to-lot purity variances and untraceable contamination risks. PX1 Research eliminates these risks by conducting all peptide synthesis and analytical testing strictly within USA-based facilities.
Our manufacturing partners operate under current Good Manufacturing Practice (cGMP) guidelines and utilize ISO 17025 accredited analytical testing laboratories. Every step of the production cycle—from raw amino acid sourcing to solid-phase peptide synthesis, HPLC purification, freeze-drying, and final packaging—is tracked through lot-specific batch records.
To ensure rapid delivery for ongoing research schedules, PX1 Research dispatches orders same-day Monday through Friday from our centralized distribution hubs in California and Arizona. This infrastructure guarantees that research facilities receive certified reagents without logistics delays or customs holds.
What is NA Semax and how does it differ from standard Semax?
NA Semax (N-Acetyl Semax) is a synthetic analog of the ACTH(4-10) fragment with an added N-terminal acetyl group. This structural modification enhances resistance to aminopeptidase enzymes in biological matrices compared to unmodified Semax.
What primary mechanisms are studied with NA Semax in preclinical research?
Preclinical studies focus primarily on NA Semax's modulation of Brain-Derived Neurotrophic Factor (BDNF) expression, TrkB signaling pathways, cellular responses to hypoxic or ischemic stress, and inflammatory cytokine regulation in neuronal models.
What analytical purity level is guaranteed for NA Semax from PX1 Research?
PX1 Research guarantees a minimum purity of 99% for NA Semax, verified through lot-specific reverse-phase High-Performance Liquid Chromatography (RP-HPLC) and mass spectrometry (MS).
How is endotoxin content measured for NA Semax lots?
Every lot undergoes Limulus Amebocyte Lysate (LAL) endotoxin testing to ensure levels remain below strictly controlled thresholds (typically <0.1 EU/mg), preventing LPS contamination from interfering with cell culture assays.
What solvents should be used for reconstituting NA Semax in a laboratory setting?
Reconstitution is typically performed using sterile laboratory-grade Bacteriostatic Water or sterile 0.9% Sodium Chloride. Solvents should be added gently down the vial wall and mixed by gentle swirling rather than aggressive vortexing.
How should lyophilized NA Semax be stored upon delivery?
Lyophilized NA Semax should be stored at -20°C or -80°C in a dry environment shielded from light. Reconstituted solutions should be aliquoted and stored at 2°C to 8°C for short-term use or frozen at -20°C to prevent freeze-thaw degradation.
Where is PX1 Research NA Semax manufactured and shipped from?
All NA Semax supplied by PX1 Research is manufactured in USA-based, GMP-compliant facilities and shipped directly from distribution centers in California and Arizona with same-day dispatch Monday through Friday.
Can NA Semax be ordered in bulk for institutional research accounts?
Yes, PX1 Research provides institutional and bulk procurement through our wholesale portal, offering batch traceability, custom lot allocation, and comprehensive analytical documentation.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.